期刊文献+

犬经皮插管肾动脉注射人HGF基因的实验研究 被引量:3

Intrarterial administration of naked plasmid encoding human hpatocyte growth factor in canines
下载PDF
导出
摘要 目的:运用介入插管技术,经犬肾动脉快速注射含人肝细胞生长因子(HGF)重组基因的质粒(pCMV鄄HGF)。检测不同时间犬肾脏组织中外源性人HGF蛋白的水平,了解外源性HGF基因在犬肾脏组织内的表达情况。方法:健康成年犬6只,在麻醉和无菌条件下均经左肾动脉介入插管。其中4只注射pCMV鄄HGF质粒,1只注射空质粒(pcDNA3)对照,1只为注射等渗盐水空白对照。注射后不同时间留取犬静脉血以及部分肾组织,采用ELISA方法,分别检测血清及肾组织中人HGF蛋白的水平。结果:①该实验建立的检测人重组HGF的ELISA敏感性高(15~1000ng/ml),重复性强;②接受3种不同处理的犬静脉血中均未检测到人重组HGF蛋白的存在;③注射pCMV鄄HGF质粒的犬肾组织中能够检测到人重组HGF蛋白的存在。72h肾组织中HGF的水平范围在27~667ng/mg蛋白之间。注射空质粒和等渗盐水的犬(即2号和5号犬)肾组织则无表达。结论:运用介入插管技术,经犬肾动脉快速注射pCMV鄄HGF可以在肾脏内产生基因高转染表达。 Objective: To evaluate the efficiency of gene transfer and expressio n by intrarterial injecting naked plasmid encoding human hepatocyte growth facto r (HGF). Methods: Six canines were divided into the study and the control group. Naked plasmid encoding HGF was administrated in the artery of the left kidney i n the four canines (study group), while control empty vector or saline was injec ted in an identical manner in the other two (control group). Groups of canines w ere sacrificed 3 days after injection procedure, respectively, and the left kidn eys were removed for ELISA. Results: Human HGF protein was detected in the tissu e of the left kidneys of the study group, but no detectable human HGF protein wa s found in left kidneys of the control group. Conclusion: Intrarterial administr ation of naked plasmid encoding human HGF can be an efficient method to express human HGF protein locally.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第8期524-526,共3页 Journal of Nanjing Medical University(Natural Sciences)
关键词 介入插管技术 肾动脉 肝细胞生长因子基因 质粒 interventional procedure renal artery hepatocyte growth factor (HG F) gene plasmid
  • 相关文献

参考文献9

  • 1Yang JW, Dai CS, Liu YH. Systemic administration of naked plasmid encoding hepatocyte giowth factor ameliorates chronic renal fibrosis in mice [J]. Gene Therapy, 2001, 8:1470-1479.
  • 2Shinya M, Kunio M. Reciprocal balance of hepatocyte growth factor and transforming growth factor-β1 in renal fibrosis in mice[J]. Kidney Int, 2000, 57:937-948.
  • 3Shinya M, Tsutomu K. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease [J]. J Clin Invest,1998, 101 (9):1827-1834.
  • 4Yang JW, Dai CS, Liu YH. Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis in mice [J]. J Am Soc Nephrol, 2002, 13:2464-2477.
  • 5Junwei Y, Shiping C. Sustained Expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth [J]. Hepatology,2001, 33:848-859.
  • 6Enyu I. Gene therapy approach in renal disease in the 21 st century [ J ]. Nephrol Dial Transplant, 2001, 16(suppl 5):26-34.
  • 7Eugene HK, Jeffrey ML. Gene and stem cell therapy[J].JAMA, 2001, 285(5):545-550.
  • 8Hellgren L, Drvota V. Highly efficient cell-mediated gene transfer using non-viral vectors and FuGeneTM6: in vitro and in vivo studies [J]. Cell Mol Life Sci, 2000, 57:1326-1333.
  • 9Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors [J]. Gene Therapy, 2002, 9:1647-1652.

同被引文献6

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部